Cargando…
Zolav(®): a new antibiotic for the treatment of acne
BACKGROUND: Acne is a prominent skin condition affecting >80% of teenagers and young adults and ~650 million people globally. Isotretinoin, a vitamin A derivative, is currently the standard of care for treatment. However, it has a well-established teratogenic activity, a reason for the developmen...
Autores principales: | Dinant, Alexa, Boulos, Ramiz A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809335/ https://www.ncbi.nlm.nih.gov/pubmed/27042015 http://dx.doi.org/10.2147/DDDT.S106462 |
Ejemplares similares
-
Zolav(®): a new antibiotic for the treatment of acne [Corrigendum]
Publicado: (2016) -
Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis
por: Rao, Shasha, et al.
Publicado: (2016) -
Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients
por: Ryan-Kewley, Angela E., et al.
Publicado: (2017) -
Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics
por: Iinuma, Katsuhiro, et al.
Publicado: (2011) -
Characteristics of Biofilm-Forming Ability and Antibiotic Resistance of Cutibacterium acnes and Staphylococcus epidermidis from Acne Vulgaris Patients
por: Ruchiatan, Kartika, et al.
Publicado: (2023)